The California-based pharmaceutical company Gilead Sciences, Inc. is being sued by dozens of HIV/AIDS patients who claim the company stalled the development of a safer drug in its own laboratory for the sole purpose of maximizing profits. Lawsuits claim Gilead put profits over safety The plaintiffs are seeking to hold Gilead accountable for…
Truvada maker Gilead Sciences, Inc. has recently become the target of over 1,000 lawsuits alleging bone loss and related injuries. However, the company is facing a new lawsuit of a different sort – and from an unlikely party. On November 6, 2019, the United States, on behalf of the Department of Health and Human Services,…
Since the first hip replacement was performed in 1960, patients have been relying on this operation to restore their mobility and independence. Hip replacement surgeries have become increasingly popular over the years, with more patients getting implants at a younger age. In fact, more than 300,000 of these surgeries are performed each year in the…
Scientific research links more than one HIV drug which has been manufactured by Gilead Sciences Inc. to premature bone loss. Litigation against the manufacturer alleges that Gilead was aware of these risks and downplayed them when marketing the drugs, which net the company billions of dollars in annual profits. The first tenofovir lawsuit was filed…
Earlier this month, the Superior Court of California ruled that personal injury lawsuits filed against Gilead Science, Inc. over its drug tenofovir disoproxil fumarate (TDF) can proceed. The company had attempted to dismiss the cases, which allege that HIV/AIDS medications based on TDF cause permanent kidney and bone damage. The court rejected all but one…